EGLN2 and neoplasm: We showed that depletion of PHD1 (Appendix Fig. S4A) or reconstituted expression of Beclin1 P54A (Appendix Fig. S4B,C) disrupted the binding of VHL to Beclin1 with correspondingly increased interaction between ATG14L and Beclin1 in these tumor cells.